WADR

It's you speaking!

It's you speaking!

Africa CDC in discussions with potential buyers for Aspen’s COVID vaccines

Facebook
Twitter
LinkedIn
Pinterest
WhatsApp

The Africa Centre for Disease Control, Africa CDC, said on Thursday that it is still in discussions with various potential buyers for the branded vaccine of South African pharmaceutical Aspen Pharmacare's 

Recall Aspen had on Wednesday said that its vaccine production capacity might go idle soon if it doesn't get orders.

Ahmed Ogwell Ouma, Acting Director of Africa CDC, told reporters that the African Union, does not want to see a situation where Aspen closes any of their manufacturing capacity to (produce) COVID-19 vaccines. 

The bulk of the company’s COVID-19 production lines had been meant to produce Aspenovax for Africa. 

However, its existing Aspenovax production lines are currently sitting idle.

Facebook
Twitter
LinkedIn
Pinterest
WhatsApp

Africa CDC in discussions with potential buyers for Aspen’s COVID vaccines

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *